Cardiac magnetic resonance T1 mapping of left atrial myocardium
Introduction
Atrial fibrillation (AF) is the most common arrhythmia, affects 1%–1.5% of the population and up to 10% of the elderly,1 and is associated with significant morbidity and mortality.2 Many studies highlight an association between atrial fibrosis and AF.3, 4, 5 Atrial fibrosis, an adaptive response to various insults, is mediated by excessive fibroblast proliferation resulting in the deposition of proteins within the cardiac interstitial space. Surgical biopsy and autopsy specimens from patients with AF have shown increased diffuse atrial fibrosis compared to those in sinus rhythm.6, 7, 8 Innovative studies of late gadolinium enhancement on cardiac magnetic resonance (LGE-CMR) have revealed the presence of focal/cohesive LA fibrosis before and after ablation procedures.5, 9 However, the presence of global/diffuse LA fibrosis has not been noninvasively examined.
Cardiac magnetic resonance (CMR) T1 mapping is a recently introduced technique to quantify contrast-enhanced T1 relaxation time in tissues of interest. It has been shown that an inverse linear relationship exists between contrast-enhanced left ventricular (LV) myocardial T1 time and the burden of global myocardial fibrosis.10, 11 LV T1 mapping has been used to identify reduced T1 times as a surrogate of increased fibrosis in patients with acute and chronic myocardial infarction,12 valvular disease,13 heart failure,10 nonischemic dilated cardiomyopathy,14 and hypertrophic cardiomyopathy.15 However, left atrial (LA) T1 mapping has not been investigated as a potential noninvasive measure of diffuse atrial fibrosis. The purpose of the present study was to (a) establish the feasibility of LA T1 measurements, (b) determine the range of LA T1 values in patients with AF vs healthy volunteers, and (c) validate T1 mapping vs global LA intracardiac electrogram amplitude measures as a surrogate of diffuse atrial fibrosis.
Section snippets
Patients with AF
The study protocol was reviewed and approved by the Johns Hopkins Institutional Review Board. We recruited patients referred for pulmonary vein antral isolation (PVAI) for the treatment of symptomatic AF from January 2011 to April 2012. During the course of the study, CMR was performed in 57 patients before AF ablation. We excluded 6 patients with AF from this study because of respiratory motion artifacts on CMR images. Therefore, data from 51 patients (74% man; median age 55 [interquartile
Results
Of 51 patients that underwent PVAI for the treatment of AF, 27 were undergoing their first ablation. Of all patients, AF type was paroxysmal in 20, persistent in 24, and long-standing persistent in 7 patients. Of these patients, 18 had lone AF. Table 1 summarizes baseline characteristics for the patients and healthy volunteers.
Discussion
CMR T1 mapping is a relatively new method, in which lower T1 times associate with higher degrees of myocardial fibrosis.10, 11, 12, 13, 14, 15, 19 The main finding of the present study is that CMR LA T1 mapping for noninvasive tissue characterization of the LA wall is feasible. LA T1 relaxation times were significantly lower in patients with AF vs healthy volunteers. LA T1 times were also lower in patients with AF with prior ablations vs patients with AF without prior intervention, suggesting
Conclusions
CMR T1 mapping of the LA myocardium is feasible and may be used to quantify fibrotic changes in the LA wall. Lower average LA T1 times, suggesting increased LA fibrosis, were observed in patients with AF and with increasing ablation attempts. Lower LA T1 relaxation times were also associated with lower bipolar LA voltage measurement as a method to validate our findings. LA T1 mapping may provide utility for AF management.
References (35)
- et al.
Epidemiology and natural history of atrial fibrillation: clinical implications
Am Coll Cardiol
(2001) - et al.
Relationship between atrial histopathology and atrial fibrillation after coronary bypass surgery
J Thorac Cardiovasc Surg
(2006) - et al.
Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping
J Am Coll Cardiol
(2008) - et al.
Improved outcome following restoration of sinus rhythm prior to catheter ablation of persistent atrial fibrillation: a comparative multicenter study
Heart Rhythm
(2012) - et al.
On the accuracy of cartomerge for guiding posterior left atrial ablation in man
Heart Rhythm
(2007) - et al.
Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation
J Am Coll Cardiol
(2011) - et al.
Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure
J Am Coll Cardiol
(2005) - et al.
New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation
J Am Coll Cardiol
(2008) - et al.
Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging
Am Heart J
(2010) - et al.
Assessment of myocardial fibrosis with cardiovascular magnetic resonance
J Am Coll Cardiol
(2011)
Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction
J Am Coll Cardiol
Left atrial wall thickness in paroxysmal atrial fibrillation by multislice-CT is initial marker of structural remodeling and predictor of transition from paroxysmal to chronic form
Int J Cardiol
Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation
Heart Rhythm
HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. A report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society
Heart Rhythm
Histological substrate of atrial biopsies in patients with lone atrial fibrillation
Circulation
Structural correlate of atrial fibrillation in human patients
Cardiovasc Res
Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation
Circulation
Cited by (71)
Atrial Ablation Lesion Evaluation by Cardiac Magnetic Resonance: Review of Imaging Strategies and Histological Correlations
2023, JACC: Clinical ElectrophysiologyAtrial cardiomyopathy: Diagnosis, clinical implications and unresolved issues in anticoagulation therapy
2023, Journal of ElectrocardiologyMedical image analysis on left atrial LGE MRI for atrial fibrillation studies: A review
2022, Medical Image AnalysisCardiac magnetic resonance fingerprinting: Trends in technical development and potential clinical applications
2021, Progress in Nuclear Magnetic Resonance SpectroscopyCitation Excerpt :Tissue characterization using cMRF could be used to detect abnormalities in the left atrial wall associated with atrial fibrillation, HFpEF, and diastolic dysfunction. In patients with atrial fibrillation, myocardial T1 has been reported to be shorter than in healthy subjects, and lower T1 was associated with lower intracardiac bipolar left atrium voltage [93]. In HFpEF and patients exhibiting diastolic dysfunction, an enlarged left atrium and impaired function have been observed by CMR with larger volumes and worse function having poorer prognosis [94].
The impact of tissue-tracking strain on the left atrial dysfunction in the patients with left ventricular dysfunction
2020, IJC Heart and Vasculature
The study was funded by National Institutes of Health grant K23HL089333 (to Dr Nazarian) and by the Dr Francis P. Chiaramonte Foundation and the Norbert and Louise Grunwald Cardiac Arrhythmia Research Fund.
Dr Nazarian is on the MRI Advisory Panel (unpaid) for Medtronic and is a scientific advisor to Biosense Webster; he is also the principal investigator for research funding awarded to Johns Hopkins from Biosense Webster and from the National Institutes of Health (K23HL089333). Dr van der Geest is a consultant to Medis Medical Imaging Systems.